Hervé Dombret

1.8k citations
14 papers · 1.1k indexed · 1 hit paper · h-index 9
Topics
Acute Lymphoblastic Leukemia research (11 papers)Chronic Myeloid Leukemia Treatments (6 papers)CAR-T cell therapy research (4 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Hervé Dombret

14 papers receiving 1.1k citations

Hit Papers

Blinatumomab for minimal residual disease in adults with ...20182026202020232018100200300400500

Peers

Hervé Dombret
Comparison fields: 5 of 53
  • Oncology 567
  • Public Health, Environmental and Occupational Health 542
  • Hematology 417
  • Molecular Biology 281
  • Pathology and Forensic Medicine 243
Replace Julia Stieglmaier with:
Julia Stieglmaier Germany
Prashant Tembhare India
Paulo Lúcio Portugal
T. Karakas Germany
Heiko Trautmann Germany
Loredana Elia Italy
Patricia G. Hoogeveen Netherlands
Maurizio Miglino Italy
Steve Kornblau United States
Emilienne Kühlein France
Hervé Dombret relative to Julia Stieglmaier Germany Julia Stieglmaier's profile →
Citations per field
00.5×1.5×
Julia Stieglmaier · 1×
Citations per year

Countries citing papers authored by Hervé Dombret

Since Specialization
Citations

This map shows the geographic impact of Hervé Dombret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Dombret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Dombret more than expected).

Fields of papers citing papers by Hervé Dombret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Dombret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Dombret. The network helps show where Hervé Dombret may publish in the future.

Co-authorship network of co-authors of Hervé Dombret

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Dombret. A scholar is included among the top collaborators of Hervé Dombret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Dombret. Hervé Dombret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 41
3 13
4
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemiabreakdown →
516
5 5
6 15
7 43
8 3
9 39
10 43
11 39
12 314
13 6
14 7

About Hervé Dombret

Hervé Dombret is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (11 papers), Chronic Myeloid Leukemia Treatments (6 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (417 citations), Oncology (567 citations) and Public Health, Environmental and Occupational Health (542 citations). Hervé Dombret has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Gerhard Zugmaier, Monika Brüggemann, Nicola Gökbuget, Julia Stieglmaier, Christoph Faul, Carlos Graux, Massimiliano Bonifacio, Ralf C. Bargou, Vincent Haddad and Albrecht Reichle. Their work appears in journals such as Blood, Haematologica and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026